Abstract: Poster Presentations |

The Utility of High-Frequency Chest Wall Oscillation Therapy in the Post-Operative Management of Thoracic Surgical Patients FREE TO VIEW

James S. Allan, MD, FCCP; Julie M. Garrity, RN; Dean M. Donahue, MD
Author and Funding Information

Massachusetts General Hospital, Boston, MA


Chest. 2003;124(4_MeetingAbstracts):235S. doi:10.1378/chest.124.4_MeetingAbstracts.235S-b
Text Size: A A A
Published online


PURPOSE:  Post-operative pneumonia continues to be a leading cause of mortality and morbidity in patients undergoing thoracic surgical procedures. High-frequency chest wall oscillation (HFCWO) is an established therapeutic adjunct to the management of patients affected by a variety of chronic disorders resulting in the impaired clearance of bronchopulmonary secretions. This study evaluates the utility of HFCWO in the post-operative management of thoracic surgical patients, who have a similar inability to clear bronchopulmonary secretions.

METHODS:  Twenty-five patients (ages 47–83) undergoing a wide variety of elective thoracic surgical procedures were randomly chosen to receive HFCWO as part of their routine post-operative care. HFCWO was applied by means of an air-pulse generator connected to a circumferential inflatable vest applied to the chest wall. The air-pulse generator was set to a frequency of 12Hz, and therapy was applied for 10 minutes. Routine hemodynamic and pulse oximetric data were collected before, during, and after treatment. Qualitative data regarding patient tolerance and preference (as compared to percussive chest physiotherapy) were also collected.

RESULTS:  No major adverse events were encountered during or subsequent to HFCWO. Hemodynamic and pulse oximetric data also remained stable throughout the treatment period. Eighty-four percent of patients reported little or no discomfort during therapy, and HFCWO was preferred to conventional chest physiotherapy by a 2:1 margin.CONCLUSIONS: HFCWO is a safe, well-tolerated adjunct to the routine post-operative treatment of elective thoracic surgical patients. The observation of hemodynamic stability is especially significant considering that the patients were studied in the early post-operative period, with active epidural pain management.

CLINICAL IMPLICATIONS:  These data demonstrate that HFCWO can be used safely with a high degree of patient acceptance in an acute surgical population. Moreover, HFCWO was observed to provide each patient with chest physiotherapy that was consistent in quality, with the prospect of significant cost-savings.

DISCLOSURE:  J.S. Allan, Advanced Respiratory, Inc., grant monies.

Wednesday, October 29, 2003

12:30 PM - 2:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543